Estrogen deficiency aggravates insulin resistance and induces β-cell loss and diabetes in female New Zealand obese mice

Hormone and Metabolic Research

Volumn 45, Issue 6, 2013, Pages 430-435

  Vogel, H ^a   Mirhashemi, F ^a   Liehl, B ^a   Taugner, F ^a   Kluth, O ^a   Kluge, R ^a   Joost, H G ^a   Schurmann A ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

cell failure; estrogen; hyperglycemia; obesity; ovariectomy

Indexed keywords

ESTROGEN; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CARBOHYDRATE DIET; CELL LOSS; CONTROLLED STUDY; DIABETES MELLITUS; ESTROGEN DEFICIENCY; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OVARIECTOMY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SHAM PROCEDURE;

ANIMALS; BODY WEIGHT; CELL DEATH; DIABETES MELLITUS; ESTROGENS; FEMALE; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MICE; MICE, OBESE; OBESITY; OVARIECTOMY;

MUS; RODENTIA;

EID: 84878553895     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1331700     Document Type: Article

References (27)

1. Herberg L., Coleman D. L. Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism: 1977; 26 59 98
2. Herberg L., Leiter E. H. Obesity/diabetes in mice with mutations in the leptin or leptin receptor genes. In: Sima AA F., Shafrir E. eds. Frontiers in animal diabetes research, vol. 2: animal models of diabetes. Harwood Academic Publishers Amsterdam: 2001; 63 107
3. Ortlepp J. R., Kluge R., Giesen K., Plum L., Radke P., Hanrath P., Joost H. G. A metabolic syndrome of hypertension, hyperinsulinemia, and hypercholesterolemia in the New Zealand obese (NZO) mouse. Eur J Clin Invest: 2000; 30 195 202
4. Kluge R., Scherneck S., Schürmann A., Joost H. G. Pathophysiology and genetics of obesity and diabetes in the New Zealand obese mouse: a model of the human metabolic syndrome. Methods Mol Biol: 2012; 933 59 73
5. Clark J. B., Palmer C. J., Shaw W. N. The diabetic Zucker fatty rat. Proc Soc Exp Biol Med: 1983; 173 68 75
6. Paik S. G., Michelis M. A., Kim Y. T., Shin S. Induction of insulin-dependent diabetes by streptozotocin. Inhibition by estrogens and potentiation by androgens. Diabetes: 1982; 31 724 729
7. Manrique C., Lastra G., Habibi J., Mugerfeld I., Garro M., Sowers J. R. Loss of Estrogen Receptor α Signaling Leads to Insulin Resistance and Obesity in Young and Adult Female Mice. Cardiorenal Med: 2012; 2 200 210
8. Heine P. A., Taylor J. A., Iwamoto G. A., Lubahn D. B., Cooke P. S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA: 2000; 97 12729 12734
9. Moran A., Jacobs D. R. Jr, Steinberger J., Steffen L. M., Pankow J. S., Hong C. P., Sinaiko A. R. Changes in insulin resistance and cardiovascular risk during adolescence: establishment of differential risk in males and females. Circulation: 2008; 117 2361 2368
10. Saglam K., Polat Z., Yilmaz M. I., Gulec M., Akinci S. B. Effects of postmenopausal hormone replacement therapy on insulin resistance. Endocrine: 2002; 18 211 214
11. Louet J. F., LeMay C., Mauvais-Jarvis F. Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep: 2004; 6 180 185
12. Kluth O., Mirhashemi F., Scherneck S., Kaiser D., Kluge R., Neschen S., Joost H. G., Schürmann A. Dissociation of lipotoxicity and glucotoxicity in a mouse model of obesity associated diabetes: role of forkhead box O1 (FOXO1) in glucose-induced beta cell failure. Diabetologia: 2011; 54 605 616
13. Jürgens H. S., Neschen S., Ortmann S., Scherneck S., Schmolz K., Schüler G., Schmidt S., Blüher M., Klaus S., Perez-Tilve D., Tschöp M. H., Schürmann A., Joost H. G. Development of diabetes in obese, insulin-resistant mice: essential role of dietary carbohydrate in beta cell destruction. Diabetologia: 2007; 50 1481 1489
14. Klaus S. Increasing the protein:carbohydrate ratio in a high-fat diet delays the development of adiposity and improves glucose homeostasis in mice. J Nutr: 2005; 135 1854 1858
15. Leiter E. H., Chapman H. D., Falany C. N. Synergism of obesity genes with hepatic steroid sulfotransferases to mediate diabetes in mice. Diabetes: 1991; 40 1360 1363
16. Riant E., Waget A., Cogo H., Arnal J. F., Burcelin R., Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology: 2009; 150 2109 2117
17. Park C. J., Zhao Z., Glidewell-Kenney C., Lazic M., Chambon P., Krust A., Weiss J., Clegg D. J., Dunaif A., Jameson J. L., Levine J. E. Genetic rescue of nonclassical ERα signaling normalizes energy balance in obese Erα-null mutant mice. J Clin Invest: 2011; 121 604 612
18. Stubbins R. E., Holcomb V. B., Hong J., Núñez N. P. Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. Eur J Nutr: 2012; 51 861 870
19. Jones M. E., Thorburn A. W., Britt K. L., Hewitt K. N., Wreford N. G., Proietto J., Oz O. K., Leury B. J., Robertson K. M., Yao S., Simpson E. R. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA: 2000; 97 12735 12740
20. Brown L. M., Clegg D. J. Central effects of estradiol in the regulation of food intake, body weight, and adiposity. J Steroid Biochem Mol Biol: 2010; 122 65 73
21. Eckel L. A. The ovarian hormone estradiol plays a crucial role in the control of food intake in females. Physiol Behav: 2011; 104 517 524
22. Geer E. B., Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med: 2009; 6 01 60 75
23. Radavelli-Bagatini S., Blair A. R., Proietto J., Spritzer P. M., Andrikopoulos S. The New Zealand obese mouse model of obesity insulin resistance and poor breeding performance: evaluation of ovarian structure and function. J Endocrinol: 2011; 209 307 315
24. Home P. D., Pacini G. Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents. Diabetes Obes Metab: 2008; 10 699 718
25. Stefan N., Fritsche A., Weikert C., Boeing H., Joost H. G., Häring H. U., Schulze M. B. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes: 2008; 57 2762 2767
26. Misu H., Takamura T., Takayama H., Hayashi H., Matsuzawa-Nagata N., Kurita S., Ishikura K., Ando H., Takeshita Y., Ota T., Sakurai M., Yamashita T., Mizukoshi E., Yamashita T., Honda M., Miyamoto K., Kubota T., Kubota N., Kadowaki T., Kim H. J., Lee I. K., Minokoshi Y., Saito Y., Takahashi K., Yamada Y., Takakura N., Kaneko S. A liver-derived secretory protein, selenoprotein P, causes insulin resistance. Cell Metab: 2010; 12 483 495
27. Yang S. J., Hwang S. Y., Choi H. Y., Yoo H. J., Seo J. A., Kim S. G., Kim N. H., Baik S. H., Choi D. S., Choi K. M. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab: 2011; 96 E1325 E1329